As of Q4'25, Johnson & Johnson reported a revenue surprise of 1.72% and a year-over-year revenue growth of 9.08%. This marks a continued positive trend following a period of volatility, with the latest figures showing both a positive revenue surprise and robust growth compared to previous quarters. From Q1'23 to Q4'25, the revenue surprise percentage for JNJ fluctuated, initially negative in early 2023, then turning positive from Q3'23 onward, albeit with some minor dips. The YoY revenue growth showed a sharp decline in late 2023 and early 2024, bottoming out at -42.92% in Q4'23, before rebounding strongly to 66.42% in Q4'24 and maintaining positive growth through 2025. This indicates a recovery phase with increasing consistency in both revenue performance and growth, suggesting improved operational execution and market conditions over the period analyzed.